Author

P. Schucht

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Perren· 1 shared A. Raabe· 1 shared B. Sharf Den Abu Fakher· 1 shared C. Nydegger· 1 shared C. Trefny· 1 shared E. Kashani· 1 shared E. Vassella· 1 shared J. Belmonte-Beitia· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Perren

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Unlocking the potential of miR-19b in the regulation of temozolomide response in glioblastoma patients via targeting PPP2R5E, a subunit of the protein phosphatase 2A complex

E. Kashani, K. Hlavackova, S. Haemmig, M. C. Sadowski, J. Phour, U. Baumgartner, N. Mueller-Wirth, C. Trefny, B. Sharf Den Abu Fakher, C. Nydegger, T. Maragkou, P. Schucht, A. Perren, P. Zinn, M. Luedi, , E. Vassella

This study identifies miR-19b's role in TMZ resistance in GBM by targeting PPP2R5E, showing that miR-19b attenuation enhances TMZ efficacy in cell lines and xenografts.

bioRxiv · Jan 16, 2023Cancer Biology

Computational design of improved standardized chemotherapy protocols for grade II oligodendrogliomas

V. M. Perez-Garcia, L. E. Ayala-Hernandez, J. Belmonte-Beitia, P. Schucht, M. Murek, A. Raabe, J. Sepulveda

The paper uses a mathematical model to simulate tumor response to TMZ in LGO patients, finding that extended chemotherapy cycles improve long-term efficacy and reduce toxicity.

bioRxiv · Jan 15, 2019Cancer Biology